Graham Capital Management’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-59,451
Closed -$1.28M 1520
2025
Q3
$1.28M Sell
59,451
-8,651
-13% -$197K 0.02% 312
2025
Q2
$1.5M Buy
68,102
+22,438
+49% +$492K 0.02% 448
2025
Q1
$1.02M Buy
+45,664
New +$983K 0.02% 543
2024
Q1
Sell
-16,232
Closed -$604K 1249
2023
Q4
$604K Sell
16,232
-30,087
-65% -$1.01M 0.01% 539
2023
Q3
$1.58M Buy
46,319
+2,993
+7% +$113K 0.04% 252
2023
Q2
$1.7M Sell
43,326
-16,572
-28% -$598K 0.05% 246
2023
Q1
$1.92M Buy
59,898
+17,555
+41% +$580K 0.06% 265
2022
Q4
$1.32M Buy
42,343
+8,526
+25% +$308K 0.04% 433
2022
Q3
$1.25M Buy
+33,817
New +$1.27M 0.05% 391

Other funds holding PGNY

Graham Capital Management's PGNY Position: Q4 2025 in Review

Graham Capital Management sold out of Progyny (PGNY) in Q4 2025, closing a stake of 59,451 shares — an estimated $1.28M sold.

Graham Capital Management first reported a position in PGNY in Q3 2022 and held it in 9 quarters. The position peaked at $1.92M in Q1 2023. 313 funds tracked by Wall St. Rank hold PGNY as of Q4 2025.

  • Graham Capital Management reported no remaining Progyny position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 59,451 Progyny shares in Q4 2025, an estimated $1.28M.
  • Graham Capital Management first reported a position in Progyny in Q3 2022 and held it in 9 quarters.
  • Graham Capital Management's Progyny position peaked at $1.92M in Q1 2023.
  • 313 funds tracked by Wall St. Rank held Progyny as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.